pyrroles has been researched along with Chagas Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, D; Di Giorgio, C; Kabri, Y; Mathias, F; Primas, N; Vanelle, P | 1 |
| Araujo-Lima, CF; Bastos, MM; Boechat, N; Carvalho, RCC; Castelo-Branco, FS; Felzenszwalb, I; Fiuza, LFA; Galvão, BVD; Peres, RB; Soeiro, MNC | 1 |
| Batista, DDGJ; Caljon, G; da Silva, CF; Hulpia, F; Lin, C; Maes, L; Soeiro, MNC; Van Calenbergh, S; Van Hecke, K | 1 |
| Balfour, MN; Franco, CH; Freitas-Junior, LH; Moraes, CB; Stefani, HA | 1 |
4 other study(ies) available for pyrroles and Chagas Disease
| Article | Year |
|---|---|
Synthesis and Anti-
Topics: Animals; Chagas Disease; Cricetinae; Cricetulus; Humans; Pyrroles; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compounds.
Topics: Aminoquinolines; Animals; Antimalarials; Atorvastatin; Chagas Disease; DNA Damage; Mice; Pharmaceutical Preparations; Pyrroles; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
Discovery of Pyrrolo[2,3-
Topics: Administration, Oral; Animals; Chagas Disease; Crystallography, X-Ray; Disease Models, Animal; Male; Mice; Molecular Conformation; Nucleosides; Pyridines; Pyrroles; Structure-Activity Relationship; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.
Topics: Animals; Cells, Cultured; Chagas Disease; Humans; Models, Molecular; Molecular Structure; Nitroimidazoles; Parasitic Sensitivity Tests; Pyridines; Pyrroles; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2017 |